INNOVO shorts provide stimulation to eliminate incontinence
INNOVO shorts provide stimulation to eliminate incontinence
---
DEAR DR. ROACH: I have seen news reports of many positive results from people using INNOVO, the FDA-approved shorts that provide electrical pelvic muscle stimulation, to possibly eliminate incontinence entirely. I also have heard that insurance companies may help pay the cost of these shorts. Since this may help many of your readers, can you comment on this product, which I've heard described as a "life-changer" from many of its users? -- Anon.
ANSWER: The INNOVO device uses electricity to contract the pelvic muscles and strengthen them -- a similar mechanism to doing pelvic floor (Kegel) exercises, which some women have difficulty doing. (Although both men and women may develop stress incontinence, the device is only for use in stress incontinence with women.) I wish I were as enthusiastic as you are about it, since more non-medication therapies for incontinence are definitely needed, but there are several points I need to clarify.
First, the INNOVO device is not FDA-approved. INNOVO is a Class II medical device, for which the FDA doesn't require approval. Approval is given for devices deemed to be "higher risk," and consequently, the FDA requires an extensive safety evaluation before a Class III device can be approved for use. The INNOVO device is "FDA cleared" and does not require a prescription.
I reviewed the studies examining the effectiveness of the device. Although some studies showed no difference between the INNOVO device and a placebo device that did not provide electrical stimulation, the studies that did showed a moderate benefit. One study noted 37% of women assigned to the INNOVO device found at least 50% improvement in leakage episodes, compared to 12% of women using the placebo device.
I did not find any study that showed an improvement in eliminating incontinence entirely compared to a placebo device. The device has not been shown to be better than pelvic floor exercises, which remains a preferred treatment.
I have no experience with insurance paying for this device, but the manufacturer states: "Some private insurers may provide coverage for incontinence treatments like INNOVO."
DEAR DR. ROACH: I often hear people say that an inherited/genetic disease skips a generation. This is in reference to any disease, from dementia, to breast cancer, to substance abuse, to rheumatoid arthritis (RA). I ask this because my wife's mother had severe RA, yet my wife and her sister don't show any signs of RA. Now, our daughter, at 35, has been diagnosed with RA. Is there any proven research that suggests genetic diseases skip a generation? Or is that just an old wives' tale? -- K.H.
ANSWER: I have respect for the old wives, since there is often a great deal of wisdom passed down through the ages. In the case of RA, a person who has a parent with RA is more likely to get it themselves than a person who has a grandparent with RA. Still, it is more common for RA to skip a generation than it is to show up without any family history at all.
There are several reasons a disease may skip a generation. Autosomal recessive conditions often do so. Sex-linked conditions are often "hidden" in females, but show up in their male offspring. A concept called variable penetrance may also explain why diseases skip generations.
There are more than 100 areas within the DNA that impact a person's risk for developing RA, so the situation is very complex, much more so than the single genes most people learn in school.
* * *
(c) 2023 North America Syndicate Inc.
All Rights Reserved



A perfect storm: What’s to blame for Hilton Head’s skyrocketing home insurance premiums?
Santos not first to be indicted
Advisor News
- What advisors need to know about the life settlement boom
- Report: Many Americans paying up to 45% of annual income on auto loans
- Latest state budget raises taxes on Californians, ignores voter priorities
- What advisors and clients must know about Roth conversions
- Worker retirement confidence dips to lowest level in a decade
More Advisor NewsAnnuity News
- Globe Life Inc. (NYSE: GL) Making Surprising Moves in Tuesday Session
- Why annuities are gaining traction with younger investors
- Best’s Special Report: U.S. Life/Annuity Industry Sees Bottom-Line Growth Despite 18% Decline in Total Income in First-Quarter 2026
- Globe Life Inc. (NYSE: GL) Records 52-Week High Thursday Morning
- Fortitude Re Completes $500 Million FABN Issuance
More Annuity NewsHealth/Employee Benefits News
- Largest Medicaid pediatric provider sues DeSantis administration over pay rates
- Research Conducted at University Medical Center Munster Has Updated Our Knowledge about Transgender Health (Longitudinal Trends of Health Service Utilization for Gender Dysphoria In Germany Between 2010 and 2021 Based On Health Insurance Data): Health and Medicine – Transgender Health
- Karnes County renews employee health insurance benefits
- Fresno’s Community Health System and Blue Shield end stalemate, reach new agreement
- Goliad council delays engineering decisions, approves employee health plan renewal
More Health/Employee Benefits NewsLife Insurance News
- Roberts Disability Law Sues Unum Life Insurance Company of America on Behalf of Disabled Valero Refinery Operator for Allegedly Underpaying Long-Term Disability Benefits
- Avoid the ‘summertime slump:’ Strategies to remain productive
- Globe Life Inc. (NYSE: GL) Making Surprising Moves in Tuesday Session
- Symetra Partners with PlanSource to Streamline Workforce Benefits Administration
- Royal Neighbors of America achieves record growth
More Life Insurance News